Q3 2025 Earnings Call Transcript November 14, 2025 MiNK Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

The immunology and inflammation (I&I) sector is currently witnessing a surge in strategic acquisitions and innovative drug development, as companies like Novartis and Vertex aim to capitalize on ...

Boehringer Ingelheim inks research pact with Trutino to grow cancer immunology portfolio with novel Cytokine platform: Ingelheim, Germany Saturday, February 29, 2020, 10:00 Hrs [I ...

Immunometabolism have advanced the understanding of dynamic interplay between metabolic pathways and immune responses.

With immunology and inflammation blockbusters like AbbVie’s Skyrizi and Rinvoq reeling in nearly $7 billion combined in the ...

New research comparing four different flu vaccines found that the protection offered varied greatly depending on vaccine type and age of the patient. Researchers say these findings have the potential ...

AbolerIS Pharma ("AbolerIS"), a clinical-stage biopharmaceutical company committed to improving the lives of people suffering from autoimmune diseases, today announced the publication of new ...

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune ...

This article explores how understanding the brain–immune ecosystem brings insights to the molecular mechanisms behind brain ...

CU Anschutz researchers uncovered a link between a type of mucosal immune cell and gut inflammation, finding that the cells ...

Data support NEK7 as a potential novel and differentiated therapeutic approach to modulate the NLRP3 inflammasome in multiple cardiovascular and ...

New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune system that help to protect against infection varied greatly depending on the ...